From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.

New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...

Quarterly pharmaceutical sales surpassed $15 billion for the first time as strong performance from J&J's cancer medicines offset slumping Stelara sales.

Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...

Johnson & Johnson shares surged Wednesday after the company reported second-quarter results that topped estimates and the company lifted its full-year outlook.

Five start-ups win with their developments at the “Healthy Hub” organized by several health insurers. Their apps should close ...

The Motley Fool. DATE Wednesday, July 16, 2025 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — ...

Shares of Johnson & Johnson climbed 6.8% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for their biggest one-day gain and best postearnings reaction since ...

Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research repo ...

Are you struggling with dandruff and looking for an anti-dandruff shampoo that truly works? You're not alone. While dandruff ...

So, to save you the embarrassment, we went ahead and asked those clangers for you. From whether you need to wash your hair ...

On behalf of our sponsors at Arcutis Biotherapeutics, we’re learning more about plaque psoriasis, the chronic, inflammatory skin disease that affects many ...